Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

68
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
68
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

2.8K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.8K
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

45
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering Stem Cells for Islet Replacement Therapy: Recent Advances and Barriers for Clinical Translation.

Cells·2026
Same author

Mechanisms inducing differentiation of adult islet progenitor-like cells into functional islet-like organoids.

Frontiers in transplantation·2026
Same author

Clinical and metabolic profile of adults with obesity attending lifestyle medicine clinics.

PloS one·2026
Same author

The omics revolution in obesity: from molecularsignatures to clinical solutions.

Molecular omics·2025
Same author

Longitudinal antibody titers measured after COVID-19 mRNA vaccination can identify individuals at risk for subsequent infection.

Science translational medicine·2025
Same author

Corrigendum to 'Inflammatory and hypoxic stress-induced islet exosomes released during isolation are associated with poor transplant outcomes in islet autotransplantation' [American Journal of Transplantation. Volume 24, Issue 6, June 2024, Pages 967-982].

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2025

Related Experiment Video

Updated: Apr 28, 2026

A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation
17:42

A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation

Published on: April 13, 2011

65.9K

Inflammatory response in islet transplantation.

Mazhar A Kanak1, Morihito Takita2, Faisal Kunnathodi2

  • 1Institute for Biomedical Studies, Baylor University, Waco, TX 76712, USA.

International Journal of Endocrinology
|June 3, 2014
PubMed
Summary

Controlling inflammation is key to successful islet cell transplantation for type 1 diabetes. Strategies to prevent inflammation can improve islet survival and long-term transplant outcomes.

More Related Videos

Minimizing Post-Infusion Portal Vein Bleeding during Intrahepatic Islet Transplantation in Mice
06:41

Minimizing Post-Infusion Portal Vein Bleeding during Intrahepatic Islet Transplantation in Mice

Published on: May 10, 2021

3.7K
Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice
10:43

Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice

Published on: October 31, 2007

28.3K

Related Experiment Videos

Last Updated: Apr 28, 2026

A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation
17:42

A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation

Published on: April 13, 2011

65.9K
Minimizing Post-Infusion Portal Vein Bleeding during Intrahepatic Islet Transplantation in Mice
06:41

Minimizing Post-Infusion Portal Vein Bleeding during Intrahepatic Islet Transplantation in Mice

Published on: May 10, 2021

3.7K
Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice
10:43

Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice

Published on: October 31, 2007

28.3K

Area of Science:

  • Immunology
  • Transplantation Biology
  • Endocrinology

Background:

  • Islet cell transplantation offers a potential cure for brittle type 1 diabetes and refractory chronic pancreatitis.
  • Current challenges in islet transplantation include achieving high frequency and long-term graft survival.
  • Inflammation is a major contributor to early islet damage and graft loss post-transplantation.

Purpose of the Study:

  • To review recent advancements in understanding the role of inflammation in islet transplantation.
  • To explore strategies for preventing inflammation-induced damage to transplanted islets.
  • To highlight the potential of anti-inflammatory approaches to improve islet engraftment and transplant success.

Main Methods:

  • Review of current literature on inflammation in islet transplantation.
  • Analysis of cell signaling pathways involved in inflammatory responses to cytokines.
  • Discussion of pre- and peritransplant inflammatory events impacting islet quality.

Main Results:

  • Inflammatory responses are the primary cause of early islet damage and graft loss.
  • Cytokines and inflammatory events during procurement, preservation, isolation, and infusion significantly harm islets.
  • Understanding molecular mechanisms of inflammation is crucial for developing therapeutic strategies.

Conclusions:

  • Robust control of pre- and peritransplant islet inflammation can enhance post-transplant islet survival.
  • Anti-inflammatory strategies show promise for improving islet engraftment.
  • Further research into inflammatory mechanisms will drive the development of more effective islet transplantation therapies.